Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Tilray, Inc.
  6. News
  7. Summary
    TLRY   US88688T1007

TILRAY, INC.

(TLRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Social Buzz: Wallstreetbets Stocks Mixed as Facebook Slides on Revenue Advisory

07/29/2021 | 10:13am EDT


ę MT Newswires 2021
All news about TILRAY, INC.
04:49pCANNABIS BRIEF : Aurora Says Shutdown Effects 8% of Global Workforce, according to CTV New..
MT
04:48pCANNABIS BRIEF : Aurora To Shut Down Its Edmonton Facility, a Medical Cannabis Production ..
MT
04:42pCANNABIS BRIEF : BNN Also Notes Sector Expected To Operate At An Annual Run Rate of Near $..
MT
04:41pCANNABIS BRIEF : BNN Notes the Sector Operates At An Annual Run Rate of Near $4 Billion, S..
MT
04:40pCANNABIS BRIEF : BNN Notes Today's July Retail Sales Data Showed Cannabis Sales Were Up Ne..
MT
04:36pCANNABIS BRIEF : Of The 7 Pot Stocks, Only Hexo and RIV Capital Are Seen As Outperforms at..
MT
04:36pCANNABIS BRIEF : Aurora Seen As the Only Underperform Ahead of Its Delayed Q4 Results Next..
MT
04:33pCANNABIS BRIEF : CIBC Cut Aurora to $7 from $8; Cronos Cut to US$7.50 from US$8.50; Hexo t..
MT
04:28pCANNABIS BRIEF : But CIBC Sees Tilray and HEXO As Likely Profitable Next Year In Terms of ..
MT
04:26pCANNABIS BRIEF : CIBC Noted Several Related ETFs Are Down 25% From Highs In February 2021,..
MT
More news
Analyst Recommendations on TILRAY, INC.
More recommendations
Financials (USD)
Sales 2022 1 033 M - -
Net income 2022 104 M - -
Net Debt 2022 - - -
P/E ratio 2022 57,2x
Yield 2022 -
Capitalization 5 400 M 5 400 M -
Capi. / Sales 2022 5,23x
Capi. / Sales 2023 4,05x
Nbr of Employees 2 100
Free-Float 96,3%
Chart TILRAY, INC.
Duration : Period :
Tilray, Inc. Technical Analysis Chart | TLRY | US88688T1007 | MarketScreener
Technical analysis trends TILRAY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 12,02 $
Average target price 17,32 $
Spread / Average Target 44,1%
EPS Revisions
Managers and Directors
Irwin David Simon Chairman & Chief Executive Officer
Carl A. Merton Chief Financial Officer
Joshua Eades Chief Science Officer
Catherine Jacobson Vice President-Regulatory & Medical Affairs
Lloyd Brathwaite Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
TILRAY, INC.40.80%5 224
JOHNSON & JOHNSON4.16%431 543
ROCHE HOLDING AG10.05%322 644
PFIZER, INC.19.32%246 414
NOVO NORDISK A/S50.62%232 291
ELI LILLY AND COMPANY35.22%206 972